Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT06966050

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Quality-of-life Questionnaire

Study Details

Brief summary:

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Conditions

Breast Cancer

Study ID

NCT06966050

Start date

May 5, 2025

Status verified date

May, 2026

Completion date

May 31, 2032

Anticipated

Primary completion date

May 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Female or males ≥18 years of age with the ability to understand and sign a written
  • Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
  • Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
  • Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
  • Participants must be English-speaking.

Exclusion Criteria:

\-

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Arms

Group 1

Participants will fill out a quality-of-life questionnaire and complete a MRD test.

Interventions

Quality-of-life Questionnaire

Participants will be asked to fill out a quality-of-life questionnaire, which will take about 10-15 minutes to complete.

Primary outcome measure

  • European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts and Locations

Central contacts

Sadia Saleem, MD

281-566-1900ssaleem@mdanderson.org

Angela Alexander

713-792-9137aalexand@mdanderson.org

Locations

MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Sadia Saleem, MD

281-566-1900ssaleem@mdanderson.org

Angela Alexander

713-792-9137aalexand@mdanderson.org

Principal Investigator:

Sadia Saleem, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

May 20, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-05-20.